[ Price : $8.95]
FDA grants Cerevel Therapeutics a fast track designation for CVL-871, a selective dopamine D1/D5 partial agonist in development fo...[ Price : $8.95]
FDA opens a five-year collaboration with ConcertAI to evaluate real-world outcomes and safety in cancer treatments.[ Price : $8.95]
Attorney Jeffrey Shapiro says legislation sponsored by Sen. Rand Paul to have CMS take the lead in the regulation of laboratory-de...[ Price : $8.95]
Federal Register notice: FDA seeks comments on the use of study data exchange standards from stakeholders involved in study conduc...[ Price : $8.95]
Federal Register notice: FDA announces that it received a petition requesting exemption from the premarket notification requiremen...[ Price : $8.95]
OGD Office of Research and Standards director Robert Lionberger describes steps FDA has taken to foster the development of complex...[ Price : $8.95]
FDA says Sanofi did not submit sufficient data to justify approving an Aubagio sNDA for an indication for pediatric patients with ...[ Price : $8.95]
FDA approves Stratatechs StrataGraft, a cellularized scaffold for treating adult patients with certain thermal burns.